Floatz logo

Capecitabine

Bipolar

Lindner Center of HOPESmall moleculePhase 3Dormant
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Bipolar cohort.

Asset / SponsorPhaseRating
ETOMIDATE
Yeongseok Yun
Phase 4BB
Remimazolam
Yeongseok Yun
Phase 4BB
Meperidine
Yeongseok Yun
Phase 4BB
Lisdexamfetamine
Lindner Center of HOPE
Phase 3C

Same molecule, other indications

Capecitabine is also rated in:

Locally Advanced Rectal CancerDormant
BBB
Indicative ·
75 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →
rectal carcinomaDormant
BBB
Indicative ·
73 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →